98%
921
2 minutes
20
The goal of this meta-analysis was to study nasal nitric oxide (nNO) measurements in allergic rhinitis (AR) and non-allergic rhinitis (non-AR). The protocol was registered with PROSPERO (no: CRD4202124828). Electronic databases from PubMed, Google Scholar, Scopus, Web of Science, and Cochrane were all thoroughly searched and studies were chosen based on the qualifying requirements. The quality of the studies was evaluated by Joanna Briggs Institute evaluation tools, and publication bias using funnel plots. The meta-analysis included 18 studies, whereas the systematic review included 20 studies, totaling 3097 participants (1581 AR, 458 non-AR, and 1058 healthy/control). Patients with AR had significantly greater nNO levels than the control group, although this did not change significantly before or after treatment. AR patients had significantly greater nNO levels than non-AR patients, but there was no significant difference between non-AR patients and healthy controls. Nineteen of the studies were of high quality and the remaining one was of moderate quality. nNO measurement has a promising role in the management of AR and non-AR patients, but more investigations are needed to document clinical benefits.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11042547 | PMC |
http://dx.doi.org/10.14639/0392-100X-N2634 | DOI Listing |
Eur Urol
August 2025
Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC, USA.
Background And Objective: Although validated prognostic models exist for men with metastatic castration-resistant prostate cancer (mCRPC), current tools do not incorporate genomic biomarkers such as circulating tumor DNA (ctDNA) aneuploidy or pathogenic genetic alterations (PGAs). This study aimed to estimate the prevalence of PGAs in ctDNA, assess their correlation with ctDNA aneuploidy fraction, and evaluate their association with overall survival (OS). Additionally, we developed and validated a clinical-genetic (CG) model to predict OS.
View Article and Find Full Text PDFAuris Nasus Larynx
August 2025
Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China; Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Sixth People's Hospital Affiliated to S
Objective: The objective of this study was to compare the short-and medium-term effectiveness of Mupirocin ointment (2 %) (MUO) and recombinant bovine basic fibroblast growth factor eye-gel (bFGF) in the treatment of recurrent anterior epistaxis (RAE) in children.
Material And Methods: children with RAE were randomly allocated into MUO group or bFGF group. The recurrence epistaxis,epistaxis severity score (ESS),and visual analog scale (VAS) were compared among two groups at 4 weeks and 3 months.
PLoS One
July 2025
Department of Occupational Therapy, School of Rehabilitation Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Augmented reality (AR) enables users to view the real world with enhanced digital information, making it a transformative tool in education. Virtual patients (VPs) technology is also defined as "a specific type of computer-based application that simulates real-world clinical scenario. AR and VPs offer interactive and immersive learning experiences, with AR enhancing the understanding of complex concepts and VPs providing hands-on practice in clinical scenario.
View Article and Find Full Text PDFMed Clin (Barc)
August 2025
Sección de Neurología Vascular-Centro de Ictus, Hospital General Universitario Gregorio Marañón, Madrid, España.
Introduction: The management of patients with atrial fibrillation (AF) after an intracerebral haemorrhage (ICH) is controversial. We analysed the cumulative rates of ICH, ischaemic stroke (IS) and mortality in a cohort of patients with ICH+AF and compared them according to the treatment chosen.
Methods: Retrospective single-centre study of patients with ICH+AF.
Front Immunol
June 2025
HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
Background: The effect of human leukocyte antigen (HLA) mismatch on acute rejection (AR) in liver transplantation (LT) is controversial. This study aimed to investigate the effect of donor-recipient mismatch at the HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, and -DPB1 loci on AR in LT.
Methods: In total, 92 patients who underwent LT were selected for investigation from 1 January 2018 to 30 June 2024, and the donors of these patients were also from the same hospital.